We need to get companies investing in antibiotics: The growing phenomenon of antibiotic resistance is rendering the most common antibiotics useless and very few new ones are being developed, suggesting we may be headed into a “medical dark age,” the Financial Times says (watch, runtime: 4:35). World Health Organization numbers indicate the phenomenon is already killing at least 700k people a year and is on track to kill 10 mn a year by 2050, unless policymakers step in and introduce incentives for pharma companies to go to market. Because the reward to develop new antibiotics isn’t there for those who “live in the profit world,” none have been put out in the past 30 years, suggesting market incentives are necessary to resolve the issue.